© 2017 by ULURU Inc.

ULURU

ADVANCED TOPICAL SOLUTIONS

MISSION

We are a specialty medical technology company committed to developing and commercializing innovative wound care and drug delivery systems based on our patented technologies.

 

Our mission is to improve the lives of patients the world over by delivering comprehensive solutions that optimize outcomes for the key stakeholders in our healthcare systems: patients, providers and payers.

 

TECHNOLOGY PLATFORMS

Two Patented Technology Platforms with Numerous Applications

Wound Healing Technology: Altrazeal®

Altrazeal® is a new class of material designed to optimize the wound bed environment and accelerate healing. Produced as a sterile powder, Altrazeal® is unique in application and performance on a moist wound surface. When applied to a moist wound, the powder interacts with wound exudate and hydrates. Hydration with exudate causes the powder to aggregate irreversibly and form a moist wound dressing which conforms to the surface of a wound bed and seals the wound. 

Please click on the black button to access the Altrazeal® transforming powder dressing website:

Transmucosal Drug Delivery: OraDisc

A novel, patented, cost-effective, commercially-viable, water-erodible pharmaceutical carrier device, the multi-layered device may be applied to mucosal surfaces, and adheres immediately, delivering actives to treat specific localized diseases/disorders. OraDisc technology can deliver drugs systemically across the mucosal surface or for the release of drugs into the oral cavity. The device causes minimum discomfort, is easy to apply and capable of providing tailored erosion rates to deliver therapeutics over different time intervals.

Please reload

 
 

LEADERSHIP

Vaidehi Shah, Chairman & CEO

Ms. Vaidehi Shah has over sixteen years of business management and investment experience. As Founder and Managing Director of Velocitas Healthcare, Ms. Shah developed a global distribution platform for small and medium sized enterprises with innovative medical devices spanning over 50 countries. She also served as Chief Executive Officer of the Daotec Group, an Austrian technology business offering communications and mobile payment services in over sixty countries. During her three years at Daotec, she led its transformation from a telecom services provider into an international, financially regulated payment service institution. 
 
Prior to founding Velocitas, Ms. Shah spent over a decade as an investment professional at leading financial institutions such as Goldman Sachs, The Carlyle Group, Eton Park and the World Bank where she executed public and private debt and equity investments. During this time, she also helped accelerate growth at a number of her investee companies by devising and implementing new financial and business strategies. 
 
Ms. Shah currently serves as an advisor to TEAMFund Inc., an impact investor in innovative medical technologies that address unmet health needs in the world’s most underserved areas including India and Sub-Saharan Africa.  Ms. Shah also serves as a Regional Director of the Harvard Healthcare Alumni Association in Austria. She received her M.B.A. from Harvard Business School and graduated summa cum laude and Phi Beta Kappa from Wellesley College, with a B.A. in Mathematics and Economics. 

Arindam Bose, Director

Mr. Bose brings over fifteen years of experience in capital raising, private equity, wealth management and client relationship management. He has successfully concluded over one billion dollars in equity finance transactions over his investment banking and asset management career.  He is a co-founder and partner of Velocitas Partners LLC, an investment management company which invests in innovative medical technologies. As head of Etihad financial advisors, a Emirates Securities and Commodities Authority licensed financial advisory firm, Arindam has developed deep networks in the MENA region.  

 

Previously, Mr. Bose was a Partner at Al Masah Capital, a UAE based investment fund with over one billion dollars under management. Before that, he was a Director in the Global Banking and Markets Group at Royal Bank of Scotland, where he was responsible for originating and managing transactions for its investment banking business. His previous roles have included International Private banking at Coutts & Company, The National Investor and Government of Dubai and the World Bank Group.

Mr. Bose is a member of the Board of Directors of Velocitas Partners, Gulf Pinnacle Logistics, Naturo Virgin Agro Farm, Agile Financial Tech, Carving Futures Pte, Karu Design & Marketing Pvt ltd. He completed his executive training at Manchester University and received his Bachelors in Engineering from Barkatullah Vishwavidyalaya. Arindam is fluent in English, Hindi and Bengali. 

Bradley Sacks, Director

Mr. Sacks is an investor and advisor, and has been the Managing Member of Centric Capital Ventures LLC, a private investment entity, since 2009. Centric Capital has a 50% ownership position in a company that has licensed the rights to Altrazeal® for distribution in South Africa.

 

From 2006 until 2009, Mr. Sacks was the Managing Director, Global Head of Technology, Media and Telecom M&A, of Bank of America Securities.

 

During the past five years, Mr.Sacks has served on the board of directors of Gondwana International Networks (Pty) Limited (South Africa), Care Fertility Group Limited and numerous companies that are subsidiaries of General Healthcare Group, the largest private services provider in the UK.

Anish Shah, Director

Mr. Shah is a serial entrepreneur, with over twenty-five years of experience in senior management positions in diverse industry sectors. Throughout his career, Mr. Shah has gained a strong reputation for making unviable products viable and has amassed significant experience in all aspects of business management ranging from manufacturing to marketing in various international markets. Mr. Shah is also a co-founder and partner of Velocitas Partners, an asset management firm that invests in innovative healthcare companies. 

Prior to joining ULURU Inc., Mr. Shah served as the Director of International Expansion at SPPL Group, a generic drugs manufacturer with two manufacturing facilities with over 400 products. Under his supervision, SPPL became an international, financially regulated export institution with a sale network in over twenty countries in Africa and Latin America.  Prior to that, he served in senior management capacities providing support in various functional areas to a number of other small and medium sized companies including PCI and Shreeram Group of Companies.
 
Mr. Shah began his career at Arthur Anderson, after receiving his BCOM from Mumbai University and participating in the CFA and ICWA programs. Anish is fluent in English, Hindi, Gujarati and Marathi.

Oksana Tiedt, Director

Ms. Tiedt has over fifteen years of experience in global private equity, fund of funds and investment banking in diverse industries. She is a co-founder and partner of Velocitas Partners LLC, an asset management company which invests in innovative medical technologies.  

 

Prior to founding Velocitas, Ms. Tiedt led Swift Capital’s European Private Equity Fund of Funds portfolio with over one billion dollars of assets under management.  Before that, she spent seven years at Bain Capital, a global investment firm managing over $65 billion in assets. Based in their Munich and London offices, Ms. Tiedt originated and executed leveraged buyout transactions. During this time, she also served as a Director and Strategic and Financial Advisor for two private companies. Ms. Tiedt has also worked at Goldman Sachs's mergers and acquisitions group, Nissho Iwai Trading Company and at the National Defense University.
 
Ms. Tiedt received her MA in International Economics and International Relations with a focus on Japan Studies from the Johns Hopkins University School of Advanced International Studies (SAIS) and completed her BA in Economics and Asian Studies from Willamette University. She is fluent in German, Russian and English. 

Please reload

 

CONTACT US

ULURU Inc.

4410 Beltway Drive, Addison TX 75001

T: +1 (214) 905-5145

F: +1 (214) 905 5130